Myoridge Co.
Latest round
- Series C
Last raised
- Mar 2021
Total raised
- $3.5M
Investors
- 4
About Myoridge Co.
Myoridge Co.Founded in 2016 in Kyoto-shi, Japan, Myoridge Co. Ltd. focuses on innovative cell culture solutions.765 million., Ltd. specializes in the development and commercialization of innovative cell culture media designed to optimize the growth and functionality of various cell types, particularly mesenchymal stem cells (MSCs) and T cells. Their core product line includes proprietary formulations that enhance tissue factor (TF) expression in MSCs, critical for applications in regenerative medicine and cellular therapies. These products cater to pharmaceutical, biotechnology, and academic research sectors, serving a diverse clientele involved in drug development, tissue engineering, and regenerative medicine across markets such as Japan, the United States, and Europe.Myoridge's revenue model is primarily driven by direct sales of its proprietary media products and consulting services, focusing on a business-to-business (B2B) market. Transactions occur through established partnerships with research institutions and biotechnology companies, where clients purchase customized cell culture media formulations for applications, including drug screening and development. Flagship offerings like the patented CarmyA®-Monkey media and Ex-iPS Cell Medium provide revenue through one-time purchases and potentially long-term supply contracts.In April 2022, Myoridge Co. Ltd. The company plans to expand its market reach into new regions, including the United States and Europe, by 2023.
Who invested in Myoridge Co.
4 investors across 3 rounds
See all investors in Myoridge Co.
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Myoridge Co.
Who invested in Myoridge Co.?
Myoridge Co. has 4 investors on record across 3 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Myoridge Co. raised?
Myoridge Co. has raised 3 venture rounds. Sign up free to see how much each round raised and the total.
When did Myoridge Co. last raise money?
Myoridge Co.'s most recent round on record is a Series C, in Mar 2021.
What does Myoridge Co. do?
Myoridge Co. is a biotechnology company.
Where is Myoridge Co. headquartered?
Myoridge Co. is headquartered in Kyoto-shi, Japan.
Which VCs invest in companies like Myoridge Co.?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Hui Hua Fund, Yufu Capital and ICBC Capital Management back biotechnology companies at Myoridge Co.'s stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like Myoridge Co.? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.